Skip to main content
Organigram Holdings Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.030
-0.030 (-2.83%)
Mar 28, 2025, 4:00 PM EDT - Market closed

Organigram Holdings Revenue

Organigram Holdings had revenue of 42.73M CAD in the quarter ending December 31, 2024, with 17.21% growth. This brings the company's revenue in the last twelve months to 166.12M, down -0.18% year-over-year. In the fiscal year ending September 30, 2024, Organigram Holdings had annual revenue of 159.84M with 7.13% growth.

Revenue (ttm)
166.12M CAD
Revenue Growth
-0.18%
P/S Ratio
1.18
Revenue / Employee
184,984 CAD
Employees
898
Market Cap
135.77M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Sep 30, 2024159.84M10.64M7.13%
Sep 30, 2023149.21M3.40M2.33%
Aug 31, 2022145.81M66.65M84.19%
Aug 31, 202179.16M-7.63M-8.79%
Aug 31, 202086.80M6.38M7.94%
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Aug 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

OGI News

More News